Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;29(1):104-110.
doi: 10.1111/cns.13983. Epub 2022 Oct 2.

The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature

Marlena Ornowska  1 , Andrew Wormsbecker  2   3 , Gary Andolfatto  4 , Tim S Leung  2   5   6 , Idan Khan  2   4 , George Medvedev  2   7
Affiliations

The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature

Marlena Ornowska et al. CNS Neurosci Ther. 2023 Jan.

Abstract

Aims: The objective of this article is to summarize the state of the literature surrounding the use of ketamine as a neuroprotective agent following cardiac arrest.

Methods: Five electronic databases were used to search for studies related to the use of ketamine for neuroprotection following cardiac arrest. This search was performed once in May 2020, and an updated search was conducted in May 2021 and March 2022.

Results: All searches combined retrieved 181 results; no clinical trials were identified. As such, the authors were limited to writing a scoping review of the literature rather than a systematic review.

Conclusions: The current state of the literature describes the mechanism of action of ketamine as a neuroprotective agent through its action as an NMDA antagonist. There is evidence of its efficacy as a neuroprotective agent in preclinical models of cardiac arrest. Current published clinical work supports the use of ketamine ameliorating neurologic outcomes in other conditions such as epilepsy, traumatic brain injury, and depression. The current state of the literature is reflective of the notion that the use of ketamine following cardiac arrest may result in improved neurologic outcomes. Future research directions should focus on the use of ketamine as a possible clinical intervention following cardiac arrest.

Keywords: cardiopulmonary resuscitation; heart arrest; ketamine; neuroprotection; neuroprotective agents.

PubMed Disclaimer

Conflict of interest statement

No authors hold any conflicts of interest.

References

    1. Myat A, Song KJ, Rea T. Out‐of‐hospital cardiac arrest: current concepts. Lancet. 2018;391(10124):970‐979. - PubMed
    1. Mędrzycka‐Dąbrowska WA, Czyż‐Szybenbejl K, Kwiecień‐Jaguś K, Lewandowska K. Prediction of cognitive dysfunction after resuscitation – a systematic review. Postepy Kardiol Interwencyjnej. 2018;14(3):225‐232. - PMC - PubMed
    1. Graham R, McCoy MA, Schultz AM, Institute of Medicine (U.S.) . Strategies to Improve Cardiac Arrest Survival: A Time to Act. The National Academies Press; 2015. 437 p. - PubMed
    1. Sekhon MS, Ainslie PN, Griesdale DE. Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a “two‐hit” model. Crit Care. 2017;21(1):90. - PMC - PubMed
    1. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30(11):2126‐2128. - PubMed

Publication types

MeSH terms